Paul Supper

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Machine Learning

Medical Education

Anti Inflammatory Drugs

Top Venues

Wiener medizinische Wochenschrift (1946)

Medical education

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Supper, Damaris Urban, Iris Acker, Florian Simon Linke, Patric Kienast, Andrea Praschinger, Anahit Anvari-Pirsch
A concept for adapting medical education to the next generations via three-staged digital peer teaching key feature cases. Wiener medizinische Wochenschrift (1946) (2022)
Paul Supper, Damaris Urban, Iris Acker, Florian Simon Linke, Patric Kienast, Andrea Praschinger, Anahit Anvari-Pirsch
A concept for adapting medical education to the next generations via three-staged digital peer teaching key feature cases. Wiener medizinische Wochenschrift (1946) (2022)
Philipp Schwabl, Eva Hambruch, Grant R Budas, Paul Supper, Michael Burnet, John T Liles, Manfred Birkel, Ksenia Brusilovskaya, Philipp Königshofer, Markus Peck-Radosavljevic, William J Watkins, Michael Trauner, David G Breckenridge, Claus Kremoser, Thomas Reiberger
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model. Biomedicines 9 (1) (2021)
Paul Supper, Andrea Praschinger, Christine Radtke
Three-staged key-feature cases promote interaction in remote education. Medical education 55 (11) (2021)
Paul Supper, Lorenz Semmler, Christine Radtke
Comments on "Use of sliced or minced peripheral nerve segments for nerve regeneration through a biodegradable nerve conduit: A preliminary study in the rat". Microsurgery (2021)
Ksenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, Adrian Szodl, Paul Supper, David Bauer, Andrea Beer, Judith Stift, Gerald Timelthaler, Georg Oberhuber, Bruno Karl Podesser, Martha Seif, Kerstin Zinober, Nataliya Rohr-Udilova, Michael Trauner, Thomas Reiberger, Philipp Schwabl
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats. United European gastroenterology journal 8 (10) (2020)